title: Preclinical and clinical evaluation of interleukin 3.
authors.affiliation: Department of Haematology, Johann Wolfgang Goethe-University, Frankfurt am Main, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Ganser
authors.forename: O G
authors.initials: OG
authors.lastname: Ottmann
authors.forename: G
authors.initials: G
authors.lastname: Seipelt
authors.forename: U
authors.initials: U
authors.lastname: Hess
authors.forename: G
authors.initials: G
authors.lastname: Geissler
authors.forename: R
authors.initials: R
authors.lastname: Merget
authors.forename: S
authors.initials: S
authors.lastname: Falk
authors.forename: A
authors.initials: A
authors.lastname: Maurer
authors.forename: M
authors.initials: M
authors.lastname: Eder
authors.forename: D
authors.initials: D
authors.lastname: Hoelzer
mesh_terms: D000740:Anemia / Q000628:therapy*; D000818:Animals; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000187:drug effects; D006801:Humans; D007377:Interleukin-3 / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D009369:Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity
chemical_list: D007377:Interleukin-3; D011994:Recombinant Proteins